{"id":878381,"url":"http://info.mzalendo.com/api/v0.1/hansard/entries/878381/?format=json","text_counter":138,"type":"speech","speaker_name":"Garissa Township, JP","speaker_title":"Hon Aden Duale","speaker":{"id":15,"legal_name":"Aden Bare Duale","slug":"aden-duale"},"content":"THAT, the Schedule to the Bill be amended - (1) in the proposed amendments to the Pharmacy and Poisons Act, Cap. 244− (a) in Section 2, by− (i) deleting the definition of the term “pharmaceutical device”; ii) deleting the definition of the term “pharmaceutical equipment”; (iii)deleting the definition of the term “pharmaceutical product”; (iv)deleting the definition of the term “Good Manufacturing Practice” and substituting therefor the following new definition− “Good Manufacturing Practice”, also referred to as “GMP”, “cGMP” or “current Good Manufacturing Practice” is the part of"}